A credit card can feel like a key, but for many people, it’s a key that doesn’t fit the lock. When credit is bad, fair, or ...

Detailed price information for Vor Biopharma Inc (VOR-Q) from The Globe and Mail including charting and trades.

Hosting Kwanzaa celebrations for more than 20 years, Malcolm X College continues to honor African heritage and culture during ...

During year ended 30 June 2025 Tectonic Gold concluded a merger with UK company Godolphin Exploration Limited and the group ...

What is the current share price of Vor Biopharma Inc (VOR)? Vor Biopharma Inc's (VOR) current share price is $12.81. This constitutes a price movement of 24.37% when compared to the share price 7 days ...

Investing.com - TD Cowen initiated coverage on Vor Biopharma, Inc. (NASDAQ:VOR) with a Buy rating on Wednesday, citing the potential of the company’s telitacicept therapy. The stock, currently trading ...

In recent months, Vor Biopharma closed a US$424.83 million shelf registration, repriced employee stock options, and reported positive late-stage clinical data for its autoimmune drug candidate ...

Vor Biopharma (VOR) has jumped onto investors’ radar after strong Phase 3 data for telitacicept in IgA nephropathy, paired with upbeat new Wall Street coverage that frames the drug’s long term ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Vor Biopharma shares fell sharply Tuesday in premarket trading after the company priced its $100 million offering below recent trading prices. Shares traded 31% lower ahead of the morning bell at ...

Vor Biopharma Inc. (NASDAQ:VOR) on Tuesday priced an underwritten public offering of 10 million shares at $10.00 per share. The gross proceeds from the offering are expected to be $100 million. In ...